Wyeth recalls 1,000-unit/mL heparin sodium injection
Wyeth recalls 1,000-unit/mL heparin sodium injection
Wyeth Pharmaceuticals and ESI Lederle are voluntarily recalling all lots of heparin sodium injection, USP (porcine-derived) 1,000 units/mL, 1 mL Dosette vials, and 10 mL and 30 mL multiple-dose vials due to the presence of clear crystals containing an antioxidant compound from the vial rubber closures. This recall does not apply to the company’s 5,000 and 10,000 unit/mL heparin sodium products.
The 1,000 units/mL, 1 mL, 10 mL, and 30 mL vials will not be available for approximately six months. The company plans to increase production of the 5,000 units/mL, 10 mL multiple-dose vials. Until the 1,000 units/mL concentration becomes available again, monthly purchases will be limited for inventory management purposes. Wholesalers, distributors, and customers who buy direct will be limited to 150% of historical purchases for the 5,000 units/mL, 1 mL Dosette and 10 mL multiple-dose vial and the 10,000 units/mL, 1 mL Dosette and 4 mL multiple-dose vial presentations. Historical data are based on purchases made between July 2001 and March 2002.
For more information, see www.fda.gov/medwatch/SAFETY/2002/safety02.htm#hepari.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.